As of 2026-10-02, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (29.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2372.1%.
The range of the Relative Valuation is (31.19) - (28.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.8x - 34.5x | 33.1x |
| Forward P/E multiples | 26.3x - 30.2x | 28.5x |
| Fair Price | (31.19) - (28.72) | (29.31) |
| Upside | -2518.1% - -2326.3% | -2372.1% |
| Date | P/E |